Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia
Pérez de Isla, Leopoldo, Ray, Kausik K., Watts, Gerald F., Santos, Raul D., Alonso, Rodrigo, Muñiz-Grijalvo, Ovidio, Diaz-Diaz, Jose Luis, Badimon, Lina, Catapano, Alberico L., Mata, PedroVolume:
286
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2019.05.003
Date:
July, 2019
Fichier:
PDF, 803 KB
2019
File converter
Plus de résultats de recherche
More benefits 
